Tricyclicazaindole derivatives

ABSTRACT

A series of novel tricyclicazaindole compounds have been prepared by condensing the appropriate 4-aminoalkylindole or a corresponding 4-aminoethoxyindole with a suitable aldehyde reagent. The resulting tricyclic derivatives are found to be useful as oral hypoglycemic agents. Preferred member compounds include 1,3,4,5-tetrahydro-3-isopropylpyrrolo(4,3,2-d, e)isoquinoline, 3,4,5,6-tetrahydro-3-isopropyl-8,10-dimethoxy-1Hazocino(3,4,5-c,d)-indole and 3,4,5,6-tetrahydro-3-isopropyl-8methoxy-1H-1,4-oxazocino(6,7,8-c,d)indole, and their pharmaceutically acceptable acid addition salts.

United States Patent McManus Se t. 9 1975 l l TRICYCLICAZAINDOLE DERIVATIVES [75] Inventor: James M. McManus, Old Lyme, Primary f 7 r Daus Conn Assistant bxamznerMary C. Vaughn Attorney, Agent, or FirmConnolly and Hutz [73] Assignee: Pfizer Inc., New York, NY.

22 Filed: Mar. 1, 1974 [57] ABSTRACT Appl. No.: 447,074

Related U.S. Application Data Division of Scr. No. 228,743, Feb. 23, 1972, Pat. No. 3,833,591.

U.S. Cl 260/3265 B; 260/3269, 424/274 Int. Cl. C07D 209/56 Field of Search 260/3265 B, 326.9

A series of novel tricyclicazaindole compounds have been prepared by condensing the appropriate 4- aminoalkylindole or a corresponding 4-aminoeth0xyindole with a suitable aldehyde reagent. The resulting tricyclic derivatives are found to be useful as oral hypoglycemic agents. Preferred member compounds include l,3,4,5-tetrahydro-3-isopropylpyrrolo[4,3,2- d,e]isoquinoline, 3,4,5,6-tetrahydro-3-isopropyl-8, l 0- dimethoxy-1H-azocino[3,4,5-c,d]-indole and 3,4,5 ,6- tetrahydro-3-isopropyl-8-methoxyl H-] ,4- oxazocino[6,7,8-c,d]indole, and their pharmaceutically acceptable acid addition salts.

3 Claims, No Drawings TRICYCLICAZAINDOLE DERIVATIVES CROSS REFERENCE TO RELATED APPLICATION This application is a division of application'Ser. No. 228.743 filed Feb. 23. I972 and now US. Pat. No. 3.833.591.

BACKGROUND OF THE INVENTION This invention relates to new and useful tricyclicazaindolc derivatives, which are effective in reducing blood sugar levels. More particularly. it is concerned with certain novel alkyl and aryl substituted tricyclicaxaindoles and their pharmaceutically acceptable acid addition salts. which are useful as oral hypoglycenic agents for lowering the blood sugar levels of diabctic subjects.

In the past. various attempts have been made by nu merous investigators in the field of organic medicinal chemistry to obtain new and useful oral hypoglycemic agents. For the most part, these efforts have principally involved the synthesis and testing of'various new and heretofore unavailable organic compounds. particularly in the area of the sulfonylureas. However, in the search for still newer and better oral hypoglycemic agents. very little is known about the activity of various ring-nitrogen compounds like the indoles and their dcrivatives. For instance. certain aminomcthylindole compounds are active. while others are not (see US. Pat. Nos. 3.459.767 and 3.542.927). On the other hand. several 5.7-dimethoxytryptamines are very active in this respect (see US. Pat. No. 3.564.0l2), but 5- methoxy and 7-methoxytryptamincs are only useful as analeptic agents (British Bat. Nos. 974.894, 974.893 and 974,895).

SUMMARY OF THE INVENTION In accordance with the present invention. it has now been rather surprisingly found that certain novel tricyclicazaindole derivatives. i.e.. non-sulfonylurcas. are extremely useful when employed as oral hypoglycemic agents for the treatment ofdiahctic subjects. The novel compounds of this invention are all selected from the group consisting of tricyclieazaindole bases of the formulac:

the aforesaid structural formulae is alkyl having from one to six carbon atoms (and. most preferably, isopropyl). or it is cyclohexyl or phenyl. Typical member compounds of the preferred class include such tricyclicazaindole compounds as l.3.4,5-tetrahydro-3- isopropylpyrrolol 4.3,2-d,e lisoquiholinc, l ,3,4,5- tetrahydro-3-isopropyl-6.8-dimethoxypyrroloI 4,3 .2- d.e Iisoquinoline. 3.4,5.(i-tetrahydro-B-isopropyl-l H- azepinoI 3 .4.5-c,d ]indole. 3 ,4,5 .6-tetrahydro-3- isopropyl-8. lU-dimethoxy-1H-azoeine[ 3.4.5-

c.d lindole and 3 .4.5 .6tetrahydro-3-isopropyl8- methoxy-l H 1 ,4-oxazocinol 6.7.8c,d ]indole. and their pharmaceutically acceptable acid addition salts such as the hydrochlorides and acetates. respectively. These particular compounds are all highly potent as regards thcirhhypoglycemic activity.

DETAILED DESCRIPTION OF THE INVENTION In accordance with the process employed for preparing the novel compounds of this invention, an appropriately substituted 4-aminoalkylindolc or a corresponding 4-aminoethoxyindole is reacted with a suitable aldehyde reagent of the formula R;,CHO. where R is as previously defined. to form the desired tricyclicazain-.

dole final product of respectively either formulaI-or II. as the case may be. This particular reaction is normally conducted in a suitable reaction-inert aprotic organic solvent in the presence of an acid at a temperature that is generally in the range of from about 20C. up to about 80C. for a period of about onehalf to about 20 hours. In practice. it is usually found most convenient touse a slight excess of the aldehyde reagent (say. for example. a 107! molar excess of reagent) and to employ an organic acid as catalyst for the reaction. Preferred aprotic solvents for use in the reaction include cyclic ethers such as dioxane and tetrahydrofuran. aromatic hydrocarbon solvents such as benzene. toluene and xylene. as well as N,N-dialkyl lower alkenoamides like N.N-dimcthylformamide. N,N-dimcthylacetamide. N.Ndicthylformamide and so on, while preferred organic acids include the lower alkanoic acids such as formic acid, acetic acid. propionic acid, and the like. with glacial acetic acid being most preferred. Upon completion of the reaction, the desired product is and the pharmaccutically acceptable acid addition salts thereof. wherein R and R are each a member selected from the group consisting of hydrogen and methoxy. n is an integer of from one to three, inclusive. and R is a member selected from the group consisting of alkyl having from one to six carbon atoms, cycloalkyl having from three to six carbon atoms, phenylalkyl having up to three carbon atoms in the alkyl moiety, phcnyl. chlorophenyl. tolyl. anisyl and thienyl. These compounds are all useful in lowering blood sugar levels when administered by the oral route of administration.

Of especial interest in this connection are the pre ferred compounds of the present invention where, R. in

readily recovered from the spent reaction mixture by using such conventional means as concentration and crystallization. etc, or else by first diluting said mixture with water, followed by hasification and subsequent extraction with an organic solvent to yield the corresponding free base compound per sc.

The aforementioned 4-aminoalkylindole starting materials, used in the reaction process of this invention for preparing the compounds of formula I, are either known compounds or else they are easily prepared by those skilled in the art from readily available materials in accordance with the standard procedures or organic chemistry for preparing classical amines. For instance.

the 4-amimnnethylindole compounds are either known or else readily prepared in two steps fromthe corresponding 4-carboxaldehyde. via formation of the intermediate oxime and its subsequent reduction with nascent hydrogen. On the other hand. the 4- aminoethylindoles are obtained by treating said aldehyde with nitromethane in a condensation reaction and reducing the resulting nitroolefin intermediate with lithium aluminum hydride. Lastly. the 4- aminopropylindoles are also obtained from said corresponding aldehyde in a series of synthetic organic steps involving l a condensation reaction with diethyl malonate (malonie ester) to yield an unsaturated diester; (2) reduction of said ester via catalytic hydrogenation to give a fully saturated compound that is subsequently hydrolyzed to the corresponding dibasic acid; (3) decarboxylation of said diacid to the corresponding monobasic acid and its subsequent conversion to an amide. and (4) reduction of said amidewith lithium aluminum hydride to give the desiredamin. These two last synthetic steps can be briefly illustrated by the following reaction schemc. where R represents the desired indole ring moiety. vi7... RCHO RCH=C- (COOC H RCH CH COOH RCH CH CONH RCH CH CH NH- The 4-aminoethoxyindole starting materials. on the other hand. used to prepare the compounds offormula II. are all new per se. but are readily prepared by those skilled in the art starting from easily available reagents and employing the conventional methods of organic chemistry. For instance. the appropriate 4- hydroxyindole compound can be simply converted to the corresponding cyanomethoxy derivative via the use of chloroacetonitrile and thereafter reduced as such to the desired amine by means of treatment with lithium aluminum hydride. as is hereinafter illustrated by the following reaction scheme where R has the same meaning as before, viz., ROH ROCH CN- ROCH CH NH The pharmaceutically acceptable acid addition salts of the tricyclicazaindole base compounds of this invention (i.e.. the final products of formulas l and vll) are prepared by simply treating the aforementioned organic bases with various mineral and organic acids which form non-toxic acid addition salts having pharmacologically acceptable anions. such as the hydro- 'of tablets. capsules. loien the intril'pcritohiiall rkulto ofadministration at levels ranging f ont 10 mg/kg. to mg/kg. respectively. without showing any substantial signs of toxic side effects. "I -he other.compounds of this invention-also cause similar-results. Further-mor'eziall the herein; described compounds of this invention can be administered orally. for thepresent purposes at hand. without causing any significant untoward pharmacological side effects to occur i'n'the subject -to whom they are so administered. In general. these compounds are ordinarily administered at dosage levels ranging from about 0.4 mg. to about '15 mg. per leg. of body weight per day. although variations will' hecessarily occure depending upon'theweight and condition of the subject being treated and -the particular type of oral formulation chosen.

In connection with the useo'f the tricyclicazaindole compounds-of this inventio'n for the treatment of diabet ic subjects. it is to benoted that they may be administered either alone or in coinbinati'on with pharmaceutically "acceptable carriersand' that such administration can be carried out in both single and multiple dosages. More particularly. the no'vel eompounds of the inven tion'canbe administeredilia wide variety of different dosage forms. i.e.. they may be combined with various phar ma ceutically-acceptable inert" carriers in the form ges. troches. hard candies. powders. aqueous 7 ns. "elixirs. syrups and the like. Such carriers include solid diluents or fillers. sterile aqueous media andNari ous non-toxic organic solvents. etc. Moreover. such dral pharmaceutical compositions can be suitably sweetened and/or flavored by means of various agentsof the type commonly employed for just such a purpose. In general. the therapeuticall'y-effective compounds ofthis invention are present in such dosage forms at concentration levels ranging from aboutl'lfifbto amateu /1 weight of the total composition. in amounts which are sufficient to provide the desired unit dosage.

For purposes of oral administration. tablets containing various e'xc epients sodium citrate. calcium carbonate and dicalcium phos phate may be employed along with various disiii tegr'ants such as starch and preferably potato or tapioca starch. alginic acid and certain complex silicates. together with binding agents chloride. hydrobromide. hydroiodide. sulfate or bisulfate. phosphate or acid phosphate. acetate. lactate. ma-

leate. fumarate. citrate or acid citrate. tartrate or bitartrate. succinatc. gluconate. saccharate. mcthanesulfonate. ethanesulfonate. benzenesulfonate and p-toluencsulfonate salts. For instance. the salt-formation step may be carried out using a substantially equimolar amount of the chosen acid in an aqueous solvent medium or in a suitable organic solvent such as methanol or ethanol. Upon careful evaporation of the solvent. the solid salt product is readily obtained.

As previously indicated. the tricyclicazaindole compounds of this invention are all readily adapted to therapeutic use as oral hypoglycemic agents. in view of their ability to lower the blood sugar levels of diabetic and non-diabetic subjects to a statistically significant degree. For instance. l.3.4.5-tetrahydro-3-isopropylpyrrolo[4.3.2-d.e ]isoquinoline. a typical and preferred agent of the present invention, has been found to consistently lower blood sugar levels in the normal fasted rat to a statistically significant degree when given by such as polyvinylpyrrolidone. gelatin and acacia. Additionally. lubricating agent s such as magnesium stearate. sodium lauryl sulfate and talc are often very useful for tabletting purposes. Solid compositions of a similar type may also be employed as fillers in soft and hardfilled gelatinicapsules; preferred materials in this connection would also includc the high molecular weight polyethylene glycols. When aqueous suspensions and- /or elixirs are-desired'for oral administration. the essential activeingredienttherein may be combined with various sweetening or flavoring agents. coloring matter or dyes and. if so desired. emulsifying and/or suspending agents as well. together with such diluents as water. ethanol. propylene glyeol .-glycerin and various like combinations thereof. i

The activity of the compounds of the present invention. as hypoglycemic agehts is determined by their ability to "lower 'bloodsugarlevels in'the normal fasted rat when testedthcrein' for-suc lr'purposes according to the procedure described WE S; Hoffman. as reported in the JUI'U'IilI/ ofBiological- ('lwn'lixlfy. Vol. 120. p. 51

(1937). The latter method measures directly the amount of glucose in the blood at any giventime and,

from this. the maximum percent decrease-in blood sugar can be rcadilycalculated and reported -as,.hypo.- glycemic activity per se. In this way. the present-tricyclicazaindole compounds are shown to markedly reduce the blood sugar levels of anesthetized rats when administered to them at dose levels as low as 32 mg./1-g. (a dose level at which chlorpropamide fails to elicit a strong response). I

EXAMPLE. 1 y To a solution consisting of 2.0g. (0.014 mole) of 4- aminomethylindole 1M. Holhel and .V. Liedc, (hum/x.- c/u' Berk-luv. Vol. 96. p. 1618 1963 lDdissolved in ml. of glacial. acetic acid. there were added 1.1 g. (0.0154 mole) of isobutyraldehyde in 42 ml. of. henzene. The resulting mixture was then .heated in an oil bath at 70.C. for a period of 1.5 hours. cooled and sub:

sequently treated with 200 ml. of ice and water. The aqueous layer was separated and made basic with aqueous sodium hydroxide. followed by extraction of same with diethyl ether. The separated ether layer was then dried over anhydrous magnesium sulfate. filtered and the dried ethereal filtrate was subsequently concentrated in vacuo to near dryness to afford 1.3g. of l.3.4.5-tetrahydro-3 isopropylpyrrolol 4.3.2- v

d.e|isoquino1ine. m.p. 177-179C. .After recrystallization from isopropyl ether. the analytical sample melted at 179l 81C. 2

Anal. Calcd. for C'mH N i C. 77.96; H. 8.05; N. 13.99. Found: C. 77.86; H. 8.04; N. 13.80.

EXAMPLE ll 7 V The procedure described in Example 1 was repeated to prepare the following 3-substituted l.3.4.5-tctrahydropyrrolol 4.3.2-d.e lisoquinolinc compounds, starting from 4-aminomethylindolc and the appropriate aldehydc (R;.CHO) reagent in each case:

l.3.4,5-tetrahydro-3-phenylpyrrolo[ 4,3.2- d.elisoquint ilinc. m.p. 208-210C.

l.3.4.5-tetrahydro-3-( sec.-butyl )pyrrolol 4.3.2 d.e]isoquinolinc. m.p. 106-108C.

l.3.4.5-tetrahydro-3cyclopropylpyrrolol 4, 3 2- d,e lisoquinoline. m.p. 208-209C EXAMPLE 111 To a solution consisting of 66.0 g. (0.37 mole of 5.7 dimcthoxyindole [R. C rohare et al.. Journal of Hererocyclic ('liemislry. ,Vol. 7. p. 729 (1970)] dissolved in 350 ml. of.dimethylformamide that was subsequently cooled to 20C.. there were added 59.6 g. (0.37 mole) of phosphorus oxychloride in 400 ml. of the same said solvent over a period of twenty minutes. while maintaining the temperature of the reaction mixturevat 2228C. throughout the course of the addition-The resulting mixture'was-thcn allowed to stir at room temperature (-25C.) for a period of one-half hour. fol lowed by the addition of same -to a mixture consisting of 6.5 liters of ice and water which also. contained 148 ml. of 20% aqueous sodium hydroxide. After stirring for an addition period of 15 minutes, the basified aqueous mixture was filtered and the productcolleeted on the filter funnel to give23.5 g. of 5.7-dimethoxy-4 -i ndolecarboxyaldchydc. m.p. '164170C. The latter crystalline material had first been washed with water on the filter funnel and then air dried to constant weight. Upon recrystallization from benzene. theanalytical sample melted at 1.74176C. and possessed the following absonption characteristics in the ultaviolet region of the spectrum. viz... at 255 and,345 mp. (where (F-710.781 and 14.750v respectively). with a shoulder at 241 mg (e=10.7 81

Anal. Calcd. for C H NO C. 64.39; H. 5.40; N. 6.82. Found: C. 64.68:, H..4.98; N. 6.76.

Asolution containing 1.02 g. (0.005 mole) of 5.7- dimethoxy-4-indolecarhoxaldehyde and 520 mg. (0.007 mole) of hydroxylamine hydrochloride in 10 ml. of pyridine was allowed to stand at room temperature (-25C.) fora period of 17 hours. The resulting reaction mixture was then poured into 8 ml. of water. and the precipitated solidiproduct thus obtained was subsequently collected by meansof suction filtration and air dried to constant weight to afford 1.05 g. of 5.7- dimethoxy-4-indoleearboxaldehyde oxime. m.p. 200-204C. After recrystallization from ethyl acetate. the analytical sample melted at 206-208C.

Anal. Calcd. for C H N- O C. 59.99; H. 5.49; N. 12.72. Found: C..60.01; H. 5.33; N. 12.48.

To a stirred suspension of 4.45 g. (0.02 mole) of 5.7- dimethoxyindolecarboxaldehyde oxime in 300 m. of ethanol there were added 29 g. of sodium pellets while the entire system was placed under a nitrogen atmosphere. Theaddi-tion was carried out at such a rate that theethanol solvent system was maintained at the reflux point throughout, although some external heat was necessary-during the last stages of the addition step in order toc'ompletely effect the: reaction.

The resulting mixture was then cautiously diluted with 300 ml.v of water. and the ethanol was subsequently removed by means of evaporation under reduced pressure to afford 3.65 g. of 4-aminomethyl--5.7- dimethoxyindole (m.p. 167C.) in the form of a solid precipitate (initially isolated by means of suction filtration and thenair dried to constant weight). Recrystallization of the analytical sample first from toluem: and then from diethyl ether finally raised the meltiitgpoint to l70.173C. Anal. Calcd. for C H N O' C. 64.06; H. 6.84: N.

13.59.'Found: C. 64.12; H. 7.05; N. 13.18.

To a suspension of 2.6 g. (0.012 mole) of 4- aminomethyl,7-dimethoxyindole in 28 ml. of henzene containing 1104 g. (0.014 mole) of isob utyraldehyde. there were added 1.2 ml. of glacial acetic acid. The resulting mixture was thenheated to reflux for a peri'odof two hours. followed by Cooling in an ice bath. The precipitate thus obtained was recovered by means of suction filtration and triturated in isopropanol to afford 940 rhg. of product as the acetic acid addition salt. melting at 199202C. The free base compound was thereafter liberated from the latter acid addition salt. by adding same to .assolution of 20% aqueous sodium hydroxide, followed by extraction with diethyl ether. 'Upon drying the ether layer in the usual manner (over anhydrous magnesium sulfate) and subsequently concentrating the resulting filtrate in vacuo, there was obtained pure 1.3.4.5tetrahydro-3-isopropyl-6,8- dimethoxypyrrolel4.3.24.6lisoquinoline as the residual base. After recrystallization from benzene. the analytical sample melted at 191194C.

Anal. .Calcd. for C, -,H .,N O- C, 69.20; H. 7.74; N. 1().76.- Found: C. 69.44; H.766; N. 10.70.

EXAMPLE IV To. 250ml. of chilled ethanol at 10C. containing .15.5 g, (0.107 mole) of 4'indolecarboxa1dehyde 1E.

Hardegger and H. (orrodL Htll'tlft't! ('lu'mit'u .-l 'm. Vol. 37. p. 1826 1954)] and 16.3 g. (0.267 mole) of nitromethane. there were added 15 g. (0.267 mole) of potassium hydroxide in 65 ml. of water and 130 ml. of ethanol. The resulting solution was then stirred at C. for a period of 1.5 hours. and thereafter poured into 3 liters of ice and water. followed by acidification with 6N hydrochloric acid. The precipitate which formed at this point was subsequently collected by means of suction filtration and immediately added to 100 ml. of acetic anhydride containing g. of sodium acetate. The resulting reaction mixture was then refluxed for a period of ten minutes. followed by removal of the anhydride under reduced pressure. The residue thus obtained was thereafter treated with 200 ml. of water and subsequently made basic by the addition of sodium acarbonate to afford a gum. Extraction of the latter material with diethyl ether. followed by drying of the ex tract and concentration to an oil in the usual manner then gave 5.2 g. of 4-(2-nitrovinyl)indole. which was immediately used in the next step without any further purification being necessary.

A solution of 6.3 g. (0.166 mole) of 4-(2'- nitrovinyl )indole in 100 ml. of tetrahydrofuran was prepared and added dropwise to a slurry of 5.2 g. (0.0276 mole) oflithium aluminum hydride in 100 ml. of the same said solvent. The addition step was carried out while the entire system was placed under a nitrogen atmosphere. Upon completion of this step. the reaction mixture was allowed to stir for an additional period of 15 minutes. followed by the addition of 600 ml. of water and 50 ml. of 2071 aqueous sodium hydroxide to the mixture in order to carefully decompose excess hydride reagent. The treated aqueous mixture so obtained was then thoroughly extracted with diethyl ether. and

.were obtained 2.2. g. of 4-(2-aminoethyl)indole in the form of a partially solid residue. A portion of the latter material was then converted to the corresponding picrate salt for analytical purposes and recrystallized such from ethyl acetate-methanol to constant melting point. The analytical sample melted at 243.5C. (dec.

Anal. Calcd. for C,.,H, N .C.;H;,N;,O C. 49.36: H. 3.88; N. 17.99. Found: C. 49.36; H. 3.90; N. 18.12.

To a solution consisting of 1.2 g. (0.00749 mole) of 4-(2-aminoethyl)indole dissolved in 15 ml. of glacial acetic acid. there was added 595 mg. (0.00824 mole) of isobutyraldehyde in ml. of benzene. The resulting reaction mixture was then heated to 50-55C.' for a period of 20 minutes. cooled and subsequently poured into 150 ml. of ice and water. The aqueous layer was separated and made basic with 20% aqueous sodium hydroxide. followed by extraction of same with diethyl ether. The separated ether layer was then dried over anhydrous sodium sulfate. filtered and the dried ethereal filtrate subsequently concentrated in vacuo to afford 590 mg. of 3.4.5.6-tetrahydro-3-isopropyl-1H- azepino-[3.4.5-c.d]indole (m.p. l7l-175C.) as the residual product. After recrystallization from toluene. the analytical sample melted at 173.5175C.

Anal. Calcd. for C H N i C. 78.46; H. 8.46; N. 13.08. Found: C. 78.72; H. 8.29; N. 12.72.

EXAMPLE V A mixture consisting of 4.9 g. (0.024 mole) of 5.7- dimethoxy-4-indolecarboxaldehyde and 1.8 g. (0.024

mole) of ammonium acetate in 20 ml. of nitromethane was heated on a steam bath for a period of 20 minutes. The reaction mixture was then cooled in an ice bath. and the precipitate which formed at this point was subsequently collected by means of suction filtration. The latter crude product was slurried in water. filtered again and then air dried to constant weight to afford 3.26 g. of pure 4-(2'-nitrovinyl)-5.7-dimethoxyindole. m.p. l59162C. After recrystallization from benzene. the analytical sample melted at 167169?C.

Anal. Calcd. for C,. ,H ,N O C. 58.06; H. 4.87; N. 11.29. Found: C. 58.23; H. 5.00; N. 11.11.

A solution of 4.2 g. (0.017 mole) of4-(2'-nitrovinyl 5.7dimethoxyindole in 85 ml. of dry tetrahydrofuran was prepared and added dropwise to a slurry of 3.8 g. (0.102 mole) of lithium aluminum hydride in ml. of the same said solvent. while the entire system was under a nitrogen atmosphere. The addition was complete in about one-half hour. The spent reaction mixture was then cooled to room temperature and the excess hydride reagent reagent carefully decomposed by the slow addition thereto of 35 m1. of 50% tetrahydrofuran-water 1 :1 by volume). The solids which formed at this point were then removed by means of til tration. and the resulting filtrate was thereafter concentrated in vacuo to provide 3.4 g. of 4-('2'-aminoethyl 5.7-dimcthoxyindole as the residual product in the form of a crude oil. A portion of the latter material was then converted to the corresponding picrate salt for analytical purposes and recrystallized as such from iso-. propanol to give pure compound. The analytical sample melted at 217220C.

Anal. Calcd. for C,- ,H N O .C..O;: C. 48.1 1; H. 4.26; N. 15.58 Found: C. 48.50; H. 4.28; N. 15.17.

To a stirred suspension of 1.1 g. (0.00499 mole) of 4-( 2'-aminocthyl)-5.7-dimethoxyindole in 10 ml. of benzene containing 2.0 ml. of glacial acetic acid. there was added 395 mg. (0.0054 mole) of isobutyraldehyde dissolved in 10 ml. of benzene. The addition step was carried out with the aid of some cooling. Upon completion of same. the reaction mixture was allowed to stir at room temperature for a period of one hour. followed by heating at .5055C. for the same period of time. The resulting mixture was then cooled. and the precipitated solid filtered and air dried to constant weight to give 1.0 g. of 3.4.5.6-tetrahydro-3-isopropyl'7.9- dimethoxy-lH-azepinol3.4.5-c.d]ind0le as the acetate salt. mp. 189C. (dcc.). After recrystallization from actonitrilc. the analytical sample melted at 192C. (dec.

Anal. Calcd. for C .H. N- ,O. ,.C. ,H O C. 64.64; H. 7.84; N. 8.38 Found: C. 64.73; H. 7.82; N. 8.26.

EXAMPLE Vl In a flask fitted with a Dean-Stark trap. there was placed a mixture consisting of 20 g. (0.097 mole) of 5.- 7-dimethoxyindole-3 carboxaldehyde. 16.8 g. (0.104 mole) of diethylmalonate. 2.0 ml. of pyridine. 2.8 ml. of glacial acetic acid and 960 ml. of benzene. The mixture was heated to reflux for a period of 36 hours. during which time water was collected in the manner indicated above. The benzene solvent was then removed by means of evaporation under reduced pressure. and the residual material obtained as product was thereafter triturated with 400 ml. of isopropyl ether to afford 29.2 g. of ethyl a-carbethoxy-S.7-dimethoxyindole-4- acrylate. m.p. l05107C. After recrystallization from ethanol-water. the analytical sample .melted at Anal. Calcd. for C H- NO C. 62.23; H. 6.09; N. 4.03. Found: C. 62.38; H. 6.25; N. 4.18.

A mixture of 1.7 g. (0.0049 mole) of ethyl (CdI'hCthoxy-5.7-dimethoxyindole-4-acrylate and 350 mg. of platinum oxide in 50 ml. of ethanol was shaken in a hy drogen atmosphere at room temperature -25C.) and at an initial pressure of 45 p.s.i.g. of hydrogen. After five hours. the theoretical amount of hydrogen uptake could be observed. The spent catalyst was then removed from the mixture by means of suction filtration, and the resulting filtrate thereafter concentrated in vacuo to afford 1.7 g. of diethyl 5.7-dimethoxy-4- indolymethylmalonate in the form of a brown solid residue. m.p. 98-l02C. After recrystallization from isopropyl ether. the analytical sample melted at 104105C.

Anal. Calcd. for C H NO C. 61.87: H. 6.64; N. 4.01. Found: C. 61.89; H. 6.67; N. 4.03.

A suspension of 5.6 g. (0.016 mole) of diethyl 5.7- dimethoxy-4-indt 1ymethylmalonate in 34 ml. of aqueous potassium hydroxide was heated to reflux for a period of one hour. The clear yellow solution which resulted was then cooled in an ice bath and slowly acidified with 6N hydrochloric acid to give a crystalline precipitate. The latter material was subsequently recovered by means of suction filtration and air-dried to constant weight to give a 4.4 g. yield of 5.7-dimethoxy- 4indolymethylmalonic acid. m.p. l4l142C. After recrystallization from ethyl acetate-pentane. the analytical sample melted at 150-l5 19C.

Anal. Calcd. for C H NO C. 57.33; H. 5.61; N. 4.78. Found: C. 57.14; H. 5.28; N. 4.56.

5.7-Dimethoxy-4indolymethylmalonic acid (5.5 g.. 0.018 mole) was pyrolyzed by a heating bath temperature of 200C. for a period of 10 minutes. while under a reduced pressure of 1.0 mm. Hg. During this time. the solid starting material was observed to melt with a vigorous evolution of gas. Upon completion of this step. the reaction mixture was cooled to room temperature. and the residue subsequently dissolved in ml. of 10% (w./v.) aqueous sodium hydroxide to give a clear solution immediately after being filtered. The cooled filtrate was then carefully acidified with concentrated hydrochloric acid. and the resulting precipitate subsequently collected by means of suction filtration and airdried to constant weight to give 3.6 g. of B-(5.7- dimethoxy-4-indole)propionic acid, m.p. 136-139C. Recrystallization of the latter material from isopropyl ether then raised the melting point of the final product to l42144C.

Anal. Calcd. for C, -,H, -,NO. C. 62.64; H. 6.07; N. 5.62. Found: C. 62.94; H. 6.22; N. 5.39.

To a chilled solution consisting of 5.0 g. (0.02 mole) of ,8-(5.7-dimethoxy-4-indole)propionic acid dissolved in 100 ml. of chloroform at 0C.. there was added 2.2 g. (0.022 mole) of triethylamine. followed by 2.4 g. (0.022 mole) of ethyl chloroformate. After allowing the reaction mixture to stir at 0C. for 10 minutes. 80 ml. of dimethoxyethane that had previously been saturated with dry ammonia gas was then added dropwise to the mixture. with continued stirring being maintained throughout the course of the addition step. Upon completion of this step. the resulting mixture was stirred in the cold for a period of one hour and then allowed to attain room temperature prior to being concentrated in vacuo. The residual solids obtained in this manner were then subsequently triturated with 80 ml.

of water. and the treated product was filtered and air dried to constant weight to give 4.6 of Ll-(5.7- dimethoxy-4-indole )propionarnide. m.p. 163 1 C. After recrystallization from toluene. the analytical sample melted at -166C.

Anal. Calcd. for C H N O C, 62.88; H. 6.50; N. 11.29. Found: C. 62.75; H. 6.59; N. 11.06.

A solution of 4.0 g. (0.016 mole) of [3-(5.7- dimcthoxy4-indole)propionamide in m1. of tetrahydrofuran. was added dropwise. while under a constant nitrogen atmosphere. to a well-stirred slurry consisting of 2.3 g. (0.06 mole) of lithium aluminum hydride in 100 ml. of the same said solvent. The addition step was carried out during the course of a 15-minute period with agitation of the mixture being maintained continuously throughout. Upon completion of this step. the reaction mixture was stirred at room temperature '-25C.) for a period of one hour. followed by a period of reflux for 1.5 hours. Water was then carefully added to the cooled mixture to decompose excess hydride. and the resulting salts were thereafter removed by means of filtration to give a clear aqueous filtrate that was subsequently concentrated in vacuo. In this manner, there was obtained a 3.4 g. yield of 4-( 3- aminopropyl)-5.7-dimethoxyindole as a yellow solid melting at 7883C. After recrystallization from isopropyl ether. the pure product melted at 92-94C.

Anal. Calcd. for C, -.H ,.N. ,O) C. 60.64; H. 7.74; N. 11.96. Found: C. 66.89; H. 7.68; N. 11.72.

A mixture consisting of 2.4 g. (0.01 mole) of 4(3- aminopropyl)-5.7-dimethoxyindole and 790 mg. (0.01 1 mole) of isobutyraldehyde in 25 ml. of benzene was allowed to stir at room temperature for a period of one hour. The resulting solution was then treated with 2.6 ml. of glacial acetic acid and the reaction mixture was allowed to stir overnight (-16 hours) at ambient temperatures. Upon completion of this step. the resulting mixture was refluxed for a period of one hour. then cooled and thereafter treated with 300 ml. of diethyl ether to afford a crystalline precipitate. The latter material was subsequently recovered by means of suction filtration and air dried to constant weight to give 1.8 g.

of 3.4.5 .6-tetrahydro-3-isopropyl8 1 O-dimethoxyl H- azocinol3.4,5-c.d]indole as the acetate salt. m.p. l68169C. After recrystallization from iso ropyl ether. the pure product melted at 176l77C.

Anal. Calcd. for C ,,H N O C H O C. 65.49; H. 8.10; N. 8.04. Found: C. 65.42; H, 7.95; N. 7.69. Found: C. 65.42; H. 7.95; N. 7.69.

EXAMPLE VII A mixture of 5.3 g. (0.02 mole) of 4-ben2yloxy-5 methoxyindole 1M. Julia et al.. Bulletin (10 ul .s'ot'ivie chimiqm' de France. p. 1417 (1965)] and 2.0 g. of 5% palladium-on-carbon catalyst in 50 ml. of ethanol was shaken in a hydrogen atmosphere at room temperature (-25C.) and 50 p.s.i.g. of hydrogen (initial pressure) for a period of 10 minutes Upon completion of this step. the catalyst was removed from the mixture by means of filtration and washed on the filter funnel with some ethanol. The aforesaid washings and filtrate were then combined and subsequently concentrated in vacuo to afford 3.0 g. of 4-hydr0xy-5-methoxyindole as a crude residual product. m.p. 148l52C. After recrystallization from diethyl ether-pentane. the analytical sample melted at l53154C.

Anal. Caled. for C,,H,,NO- C, 66.24; H. 5.56; N, 8.5) Found: C, 66.34, H, 5.60. N, 8.62.

To a well-stirred suspension of480 mg. of sodium hydrosulflte in 48 ml. of dimethylformamide. there were added 8.0 g. (0.049 mole) of .4-hydroxy-- methoxyindole. followed successively, by 2.56 g. (0.053 mole) of 507: sodium hydride and 7.36 g. (0.008 mole) of chloroacetonitrile. The resulting mixture was then allowed to stir at room temperature fora period of one hour prior to being treated with 400 ml. of water. The aqueous mixture so obtained was then carefully extracted with two-250 ml. portions of diethyl ether. and the resulting ether extracts were combined and subsequently concentrated in vacuo to afford an impure residual oil as product. The latter material was then washed free ofexcess hydride oil with benzene-hexane to give 5.6 g. of 4-cyanomethoxy-S-methyoxyindole. which was immediately used in the next reaction step without any further purification being necessary.

A solution consisting of 5.0 g (0.028 mole) of 4- eyenomethoxy-5-methoxylindole in 48 ml of tetrahydrofuran as prepared and added dropwise during the course of a -minute period to a well-stirred slurry of 2.0 g. (0.056 mole) of lithium aluminum hydride in ml. of the same said solvent, while under a dry nitrogen atmosphere at l0C. 'Ihe reaction mixture was then allowed to warm to room temperature and thereafter was stirred at that point for a period of one hour. Upon completion of this step, the excess hydride reagent was carefully decomposed by the dropwise addition of 2.0 ml. of water in l0 ml. of tctrahydrofuran to the mixture, followed by the subsequent addition of mlv of diethyl ether. The resulting solids obtained in this manner were then removed by means of suction filtration and the filtrate thereafter concentrated in vacuo to give 5.0 g. of 4(2-aminoethoxy)-5-methoxyindole in the form of a dark oil. A portion of the latter material was then made to crystallize and after a recrystallization from ispropyl ether. the product melted at 7778C.

Anal. Calcd. for C H N O C, 64.06; H, 6.84; N,

Found: C, 63.72; H, 6.65; N, 13.17.

A solution consisting of 2.0 g. (0.01 mole) of 4-(2'- aminoethoxy)-5-methoxyindole and 860 mg. (0.012 mole) of isobutyraldehyde in 50 ml. of benzene containing 3.0 ml. of glacial acetic acid was heated to 50C. for a period of 1.5 hours. Upon completion of this step, the resulting mixture was cooled and then concentrated in vacuo to remove the solvent, and the residue was thereafter triturated with diethyl ether to yield 2.3 g. of 3,4.5.6-tetrahydro-3-isopropyl-8- methoxyl H, l .4-oxazocino[6.7,8c,d ]indole as the acetate salt. m.p. l70l 7 1C. Recrystallization of a portion of the latter material from ethyl acetate then gave the analytical sample (m.p. l7)l80C.

Anal. Calcd. for C, -,H. ,,,N O .C H,O- C. 63.73; H, 7.55; N. 8.75. Found: C, 64.05; H. 7.60; N, 8.49.

EXAMPLE VIII 1 EXAMPLE IX The following tricyclicazaindole compounds are prepared by employing the appropriate procedures described in the preceding examples, starting from readily available materials in each instance and using the proper aldehyde (R CHO) reagent of choice for the final condensation step:

. The following 3..4.5.6 tetrahydrol H- l ,4oxazoeino [,6,7.8-c,d]indoles are prepared by employing the procedures of Examples VII VIII, starting from the corresponding 4-hydroxyindole compound and using the appropriate aldehyde (R3 CHO) reagent of choice as hereinbefore described:

EXAMPLE Xl The non-toxic hydrohalide acid addition salts of each of the trieyclicazaindole base compounds of this invention reported previously, such as the corresponding hydrochloride, hydrobromide and hydriodidc salts, are each individually prepared by first dissolving the respective organic base compound in absolute ether and then adding a saturated solution of the appropriate hydrohalidc gas in ethyl acetate to the aforementioned etheral solution, whereupon the desired acid addition salt soon precipitates therefrom. In this way, 5.0 g. of l,3 .4,5-tetrahydro-3-isopropylpyrrolo[ 4,3 ,2-d, elisoquinoline, obtained as a free base product in Example l, is converted via dry hydrogen chloride gas to the corresponding hydrochloride acid addition salt in almost quantitative yield.

EXAMPLE XII The nitrate, sulfate or bisulfate, phosphate or acid phosphate, acetate, lactate. maleate, furmarate, citrate or acid, citrate or bitartrate, succinate, glucenate, saccharate, methanesulfonate, ethanesulfonate, benzenesulfonate and p-toluenesulfonate salts of each of the aforementioned tricyclicazaindole base compounds re ported previously are each prepared by dissolving the proper molar amounts of the respective acid and base in separate portions of ethanol and then mixing the two solutions together, followed by the addition of diethyl ether to the resultant mixture in order to effect precipitation of the desired acid addition therefrom. In this manner, equimolar amounts of 3,4,5,6tetrahydro-3- isopropyll H-azepino[ 3,4,5-c,d indole and concentrated sulfuric acid react to afford the corresponding sulfuric acid addition salt. In like manner, each of the other salts is also similarly prepared.

EXAMPLE X"! A dry solid pharmaceutical composition is prepared by blending the following materials together in the proportions by weight specified below:

l,3,4,5-'l'etrahydro3-isoprtupylpyrrolol 4.3.3413: Iisoquinoline hydrochloride 5() Sodium citrate Alginic acid [0 Polyvinylpyrrolidone l() Magnesium stearate gredient, respectively. by merely using the appropriate amount of the tricyclicazaindole salt in each case.

EXAMPLE XIV A dry solid pharmaceutical composition is prepared by combining the following materials'together in the proportions by weight indicated below:

3,4,5.6-l'ctrahydro-li-isi)propyl-H, (l-dimcthoxy I H-uxoeincl 3.4.5-e,d lindole acetate so (alciurn carbonate :0 lol \cthylenc glycol. average molecular weight, 400K) 30 The dried solid mixture so prepared is then thoroughly agitated so as to obtain a powdered product that is completely uniform in every respect. Soft elastic and hard-filled gelatin capsule containing this pharmaceutical composition are then prepared, employing a sufficient quantity of material in each instance so as to provide each capsule with 250 mg. of the active ingredient.

EXAMPLE XV The tricyclicazaindole final products of Examples I,lIIV and Vl-Vlll were tested for hypoglycemic activity in groups of 8 10 male albino rats (each weighing l5()2()() g.) of the Sprague-Dawley strain, fasted for approximately 18-24 hours prior to administration. The rats were first lightly anesthetized with pentobarbital (at 15 mg./kg., iv), a blood sample was then taken from the tail vein and the test compound was administered intraperitoneally at dose levels of 32, 18 and l() mg./kg., respectively. Additional blood samples were then taken at l ,2 and 4 hour intervals after administration of the drug. Blood glucose was determined by adapting the method of W. S. Hoffman [Journal of Biological Chemistry, Vol. l20, p. 51 1937)] to the Autoanalyzer instrument produced by Technican Instruments Corporation of Chauncey, NY. On this basis, the maximum percent decrease in blood sugar was calculated and reported as such (i.e., as hypoglycemic activity) for the various compounds listed in the table be low:

Hypoglyccmic Activity (Maxffi Fall) What is claimed is: l. A compound selected from the group consisting of tricyclicazaindole bases of the formula ow -ll.

and the phurmueeutieuily uceeptuhle acid addition sults moietyphenyl. ehlorophenyl, tolyl. zinisyl and thienyl. thereof wherein R and R: are each 11 member selected 2. A compound as eluimed in claim I wherein R and from the group consisting of hydrogen S-methoX and R are each X-mcthoxy or lO-methoxy and R;, is alkyl IO-methoxy n is 3 and R is a member selected from the having from 1 to a enrhon atoms. group consisting of zxlkyl having from i to (v carbon 5 3. 3.45.6-Tetruhydro-3-isopropyI-8,IO-dimcthoxyatoms. eycloulkyl having from 3 to carbon atoms lH-uxoeino |3.4.5-e.d]indole, phenylulkyl having up to 3 carbon atoms in the ulkyl :l: k 

1. A COMPOUND SELECTED FROM THE GROUP CONSISTING OF TRICYCLICAZAIDOLE BASES OF THE FORMULA
 2. A compound as claimed in claim 1 wherein R1 and R2 are each 8-methoxy or 10-methoxy and R3 is alkyl having from 1 to 6 carbon atoms.
 3. 3,4,5,6-Tetrahydro-3-isopropyl-8,10-dimethoxy-1H-azocino (3, 4,5-c,d)indole. 